Contradicting experts, Fla. health chief advises seniors to avoid mRNA COVID-19 boosters
Florida health officials are raising alarms about the safety of the newest versions of mRNA COVID-19 vaccines, advising ...
Medscape5d
'Encouraging' Early Data for mRNA Vaccine in Glioblastoma
Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...
Fact Check: German study did not find mRNA shots ‘eat away’ at children’s immune systems
A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to ...
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza ...
Jim Cramer Says Moderna, Inc. (MRNA)’s Vaccine Pipeline and Cancer Advances Make It a Strong Buy
Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.
BioSpace3d
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...
AZoLifeSciences on MSN44m
Low Extracellular Sodium Concentrations Can Suppress mRNA Expression in Brain Cells
Neurological conditions can result from chronic hyponatremia, a disorder marked by low blood salt levels. In addition, ...
Florida discourages use of mRNA Covid vaccines in older adults
Even as the Covid wave in Florida continues, Gov. Ron DeSantis’ administration is once again advising against the mRNA ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRNA
New York, New York-- (Newsfile Corp. - September 18, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18 ...
Science Daily5d
Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...
Check Out What Whales Are Doing With MRNA
With a trading volume of 1,014,812, the price of MRNA is up by 0.33%, reaching $76.86. Current RSI values indicate that the ...